These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3137275)

  • 41. Interaction of the Legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. I. L. pneumophila resists killing by polymorphonuclear leukocytes, antibody, and complement.
    Horwitz MA; Silverstein SC
    J Exp Med; 1981 Feb; 153(2):386-97. PubMed ID: 7017062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes.
    Fitzgeorge RB; Featherstone AS; Baskerville A
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():53-7. PubMed ID: 3182462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium.
    Marra A; Horwitz MA; Shuman HA
    J Immunol; 1990 Apr; 144(7):2738-44. PubMed ID: 2138651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
    Walz A; Nichterlein T; Hof H
    Zentralbl Bakteriol; 1997 Feb; 285(3):431-9. PubMed ID: 9084116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic susceptibility of environmental
    Sreenath K; Chaudhry R; Vinayaraj EV; Thakur B
    Future Microbiol; 2019 May; 14():661-669. PubMed ID: 31148475
    [No Abstract]   [Full Text] [Related]  

  • 47. Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil.
    Horwitz MA
    Cell; 1984 Jan; 36(1):27-33. PubMed ID: 6692469
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of methylprednisolone on the intracellular antimicrobial activity of erythromycin and clindamycin against Legionella pneumophila.
    Higa F; Saito A; Inadome J; Kusano N; Kitsukawa K
    J Antimicrob Chemother; 1993 Jun; 31(6):901-8. PubMed ID: 8360127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity.
    Blanchard DK; Friedman H; Klein TW; Djeu JY
    J Leukoc Biol; 1989 Jun; 45(6):538-45. PubMed ID: 2498451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracellular multiplication of Legionella pneumophila in cultured human embryonic lung fibroblasts.
    Wong MC; Ewing EP; Callaway CS; Peacock WL
    Infect Immun; 1980 Jun; 28(3):1014-8. PubMed ID: 7399685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
    Moffie BG; Mouton RP
    J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review of azithromycin activity against Legionella spp.
    Edelstein PH
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic susceptibility of Legionella pneumophia Philadelphia-1 in cultured guinea-pig peritoneal macrophages.
    Yoshida S; Mizuguchi Y
    J Gen Microbiol; 1984 Apr; 130(4):901-6. PubMed ID: 6736922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.
    Vildé JL; Dournon E; Rajagopalan P
    Antimicrob Agents Chemother; 1986 Nov; 30(5):743-8. PubMed ID: 3492176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.
    Horwitz MA
    J Exp Med; 1983 Dec; 158(6):2108-26. PubMed ID: 6644240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccination with the major secretory protein of Legionella pneumophila induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease.
    Blander SJ; Horwitz MA
    J Exp Med; 1989 Mar; 169(3):691-705. PubMed ID: 2926324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophila in a mouse model of Legionnaires' disease.
    Archer KA; Roy CR
    Infect Immun; 2006 Jun; 74(6):3325-33. PubMed ID: 16714560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of inhibition of antimicrobial activity by mycobacterial lysates in human monocytes infected with Legionella pneumophila.
    Rivero-Lezcano OM; Rodríguez-Aparicio LB
    J Immunol Methods; 2008 Jul; 336(1):16-21. PubMed ID: 18436233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of cytochalasin D and methylamine on intracellular growth of Legionella pneumophila in amoebae and human monocyte-like cells.
    King CH; Fields BS; Shotts EB; White EH
    Infect Immun; 1991 Mar; 59(3):758-63. PubMed ID: 1997428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
    Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
    J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.